Sunao Manabe |
Representative Director, Executive Chairperson & CEO |
Hiroyuki Okuzawa |
Representative Director, President & COO |
Shoji Hirashima |
Representative Director, Senior Executive Officer, Head of Japan Business Unit |
Masahiko Ohtsuki |
Director, Senior Executive Officer, Head of Global DX, CDXO*1 |
Takashi Fukuoka |
Director, Senior Executive Officer, Head of Global Corporate Strategy, CStO*2 |
Wataru Takasaki |
Executive Officer, Head of R&D Division |
Hiroto Kashiwase
|
Executive Officer, Head of Technology Supervisory Division & Head of Supply Chain Division |
Koji Ogawa |
Executive Officer, Head of Global Corporate Planning & Management, CFO |
Takashi Matsumoto |
Executive Officer, Head of Global HR, CHRO*3 |
Tomoji Hashiba |
Corporate Officer, In charge of External Affairs |
Naoto Tsukaguchi |
Corporate Officer, Head of Global Leagal & IP, Head of Global Compliance & Risk, Vice President of Legal Affairs Department, General Counsel |
Akio Sakurai |
Corporate Officer, Head of Sales & Marketing Division,
Japan Business Unit |
Toshinori Agatsuma |
Corporate Officer, Vice President of Research Function, R&D Division |
Kiminori Nagao |
Corporate Officer, Head of ASCA Business Division |
Nobuo Murakami |
Corporate Officer, Vice President of Corporate Strategy Department, Global Corporate Strategy |
Hiroshi Masumoto |
Corporate Officer, Vice President of Data Intelligence Department, Global DX |
Shizuko Ueno |
Corporate Officer, Head of Medical Affairs Division,
Japan Business Unit |
Akihiro Inoguchi |
Corporate Officer, Vice President of Development Function,
R&D Division |
Toshi Kajiro |
Corporate Officer, Head of Pharmaceutical Technology Division, Technology Supervisory Division |
Hiroya Senda |
Corporate Officer, Vice President of Sales Planning Department,
Sales & Marketing Division, Japan Business Unit |
Satoru Ogawa |
Corporate Officer, Vice President of Secretariat Department |
Atsushi Tsukamoto |
Corporate Officer, Head of Therapeutic Area Strategies, Daiichi Sankyo, Inc. |
Tetsuya Iwabuchi |
Corporate Officer, In charge of Business Development |
Koji Sato |
Corporate Officer, Head of US Corporate Division, Head of Global CMC Management Oncology & DSI Pharmaceutical Technology, Daiichi Sankyo Inc. |
Tetsuya Ohira |
Corporate Officer, Vice Presindet of Corporate Planning Department, Global Corporate Planning & Management |
Koichi Nonaka |
Corporate Officer, Head of Biologics Division, Technology Supervisory Division |
Hanako Saito |
Corporate Officer, In charge of QARA*4 & CSPV*5 |
Kenji Shigeta |
Corporate Officer, Vice President of Oncology Business Department, Global Corporate Strategy |